{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:34:47Z","timestamp":1783488887898,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016112","name":"Universit\u00e0 di Foggia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016112","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Phosphaturic mesenchymal tumors (PMTs) are rare mesenchymal neoplasms of soft tissue or bone origin that can give rise to a challenge in diagnostic imaging. These tumors are frequently associated with tumor-induced osteomalacia, also called oncogenic osteomalacia, which is a rare paraneoplastic syndrome characterized by ectopic secretion of fibroblast growth factor 23, a hormone that regulates serum phosphate level. PMTs show polymorphic features on both radiological findings and histological examination, causing problems in diagnosis owing to their similarity with other mesenchymal tumors. Thus, this paper aims to describe radiological aspects of PMTs and suggest an imaging pathway for accurate diagnosis throughout the evidence from the literature review.<\/jats:p>","DOI":"10.1007\/s11547-021-01412-1","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T03:27:55Z","timestamp":1630121275000},"page":"1609-1618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway"],"prefix":"10.1007","volume":"126","author":[{"given":"Mohsin A. M.","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Pio","family":"Cafarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Paparella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston J.","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-8330","authenticated-orcid":false,"given":"Giuseppe","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"issue":"9","key":"1412_CR1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s10067-006-0468-y","volume":"26","author":"M Kaul","year":"2007","unstructured":"Kaul M, Silverberg M, Dicarlo EF, Schneider R, Bass AR, Erkan D (2007) Tumor-induced osteomalacia. Clin Rheumatol 26(9):1575\u20131579","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1412_CR2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429\u2013435","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1412_CR3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","volume":"108","author":"P Florenzano","year":"2021","unstructured":"Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT (2021) Tumor-induced osteomalacia. Calcif Tissue Int 108(1):128\u2013142","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1412_CR4","first-page":"33","volume":"16","author":"RA McCANCE","year":"1947","unstructured":"McCANCE RA (1947) Osteomalacia with Looser\u2019s nodes (Milkman\u2019s syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q J Med 16(1):33\u201346","journal-title":"Q J Med"},{"key":"1412_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02806-x","author":"E Shevroja","year":"2021","unstructured":"Shevroja E, Cafarelli FP, Guglielmi G, Hans D (2021) DXA parameters, trabecular bone score (TBS) and bone mineral density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis. Endocrine. https:\/\/doi.org\/10.1007\/s12020-021-02806-x","journal-title":"Endocrine"},{"issue":"2","key":"1412_CR6","first-page":"189","volume":"32","author":"H Wu","year":"2019","unstructured":"Wu H, Bui MM, Zhou L, Li D, Zhang H, Zhong D (2019) Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review. Mod Pathol Off J U S Can Acad Pathol 32(2):189\u2013204","journal-title":"Mod Pathol Off J U S Can Acad Pathol"},{"issue":"3","key":"1412_CR7","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18(3):R53\u2013R77","journal-title":"Endocr Relat Cancer"},{"issue":"7746","key":"1412_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(72)92844-9","volume":"1","author":"DJ Evans","year":"1972","unstructured":"Evans DJ, Azzopardi JG (1972) Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia. Lancet 1(7746):353\u2013354","journal-title":"Lancet"},{"issue":"1","key":"1412_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL et al (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28(1):1\u201330","journal-title":"Am J Surg Pathol"},{"key":"1412_CR10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bone.2012.11.040","volume":"53","author":"P Chiam","year":"2013","unstructured":"Chiam P, Tan HC, Bee YM, Chandran M (2013) Oncogenic osteomalacia-hypophosphataemic spectrum from \u2018benignancy\u2019 to \u2018malignancy.\u2019 Bone 53:182\u2013187","journal-title":"Bone"},{"issue":"10","key":"1412_CR11","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000890","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy A et al (2017) Phosphaturic mesenchymal tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum. Am J Surg Pathol 41(10):1371\u20131380","journal-title":"Am J Surg Pathol"},{"key":"1412_CR12","first-page":"18","volume":"2019","author":"Z Adnan","year":"2019","unstructured":"Adnan Z, Nikomarov D, Weiler-Sagie M, Roguin MN (2019) Phosphaturic mesenchymal tumors among elderly patients: a case report and review of literature. Endocrinol Diabetes Metab Case Rep 2019:18\u20130139","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"1412_CR13","first-page":"18","volume":"2018","author":"MP Yavropoulou","year":"2018","unstructured":"Yavropoulou MP, Poulios C, Foroulis C, Tournis S, Hytiroglou P, Kotsa K et al (2018) Distant lung metastases caused by a histologically benign phosphaturic mesenchymal tumor. Endocrinol Diabetes Metab Case Rep 2018:18\u20130023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"1412_CR14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.semdp.2019.07.002","volume":"36","author":"AL Folpe","year":"2019","unstructured":"Folpe AL (2019) Phosphaturic mesenchymal tumors: a review and update. Semin Diagn Pathol 36(4):260\u2013268","journal-title":"Semin Diagn Pathol"},{"issue":"10","key":"1412_CR15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1507\/endocrj.EJ17-0177","volume":"64","author":"T Hana","year":"2017","unstructured":"Hana T, Tanaka S, Nakatomi H, Shojima M, Fukumoto S, Ikemura M, Saito N (2017) Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the halflife of serum fibroblast growth factor 23. Endocr J 64(10):1033\u20131039","journal-title":"Endocr J"},{"issue":"10","key":"1412_CR16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s40618-018-0849-5","volume":"41","author":"JM Boland","year":"2018","unstructured":"Boland JM, Tebben PJ, Folpe AL (2018) Phosphaturic mesenchymal tumors: what an endocrinologist should know. J Endocrinol Invest 41(10):1173\u20131184","journal-title":"J Endocrinol Invest"},{"key":"1412_CR17","unstructured":"Walker BR et al (2014) Davidson's principles and practise of medicine, 22nd edn"},{"issue":"9","key":"1412_CR18","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","volume":"27","author":"Y Jiang","year":"2012","unstructured":"Jiang Y et al (2012) Tumor-induced osteomalacia: an important cause of adultonset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Miner Res 27(9):1967\u20131975","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1412_CR19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s43465-019-00005-5","volume":"54","author":"AS Kawthalkar","year":"2020","unstructured":"Kawthalkar AS, Janu AK, Deshpande MS, Gala KB, Gulia A, Puri A (2020) Phosphaturic mesenchymal tumors from head to toe: imaging findings and role of the radiologist in diagnosing tumor-induced osteomalacia. Indian J Orthop 54(2):215\u2013223","journal-title":"Indian J Orthop"},{"issue":"2","key":"1412_CR20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2214\/ajr.167.2.8686600","volume":"167","author":"NA Avila","year":"1996","unstructured":"Avila NA, Skarulis M, Rubino DM, Doppman JM (1996) Oncogenic osteomalacia: lesion detection by MR skeletal survey. AJR Am J Roentgenol 167(2):343\u2013345","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"1412_CR21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00256-013-1798-x","volume":"43","author":"MC Koplas","year":"2014","unstructured":"Koplas MC, Rubin BP, Sundaram M (2014) Phosphaturic mesenchymal tumor: two contrasting cases. Skeletal Radiol 43(6):841\u2013845","journal-title":"Skeletal Radiol"},{"issue":"3","key":"1412_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13139-015-0328-2","volume":"49","author":"CL Ho","year":"2015","unstructured":"Ho CL (2015) Ga68-DOTA peptide PET\/CT to detect occult mesenchymal tumor-inducing osteomalacia: a case series of three patients. Nucl Med Mol Imaging 49(3):231\u2013236","journal-title":"Nucl Med Mol Imaging"},{"issue":"1","key":"1412_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00256-018-3014-5","volume":"48","author":"SM Broski","year":"2019","unstructured":"Broski SM, Folpe AL, Wenger DE (2019) Imaging features of phosphaturic mesenchymal tumors. Skeletal Radiol 48(1):119\u2013127","journal-title":"Skeletal Radiol"},{"issue":"5","key":"1412_CR24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jbspin.2018.01.004","volume":"85","author":"F Busquet","year":"2018","unstructured":"Busquet F, Gahier-Penhoat M, Lescour V, Maugars Y, Guillot P (2018) Contribution of ultrasound to diagnosing a phosphaturic mesenchymal tumor. Joint Bone Spine 85(5):639\u2013640","journal-title":"Joint Bone Spine"},{"key":"1412_CR25","unstructured":"Kumar R, Folpe AL, Mullan BP (2015) Tumor-induced osteomalacia. Transl Endocrinol Metab 7(3)"},{"issue":"3","key":"1412_CR26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(99)00170-2","volume":"25","author":"S Fukumoto","year":"1999","unstructured":"Fukumoto S, Takeuchi Y, Nagano A, Fujita T (1999) Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone 25(3):375\u2013377","journal-title":"Bone"},{"issue":"1","key":"1412_CR27","first-page":"47","volume":"12","author":"K Nakanishi","year":"2013","unstructured":"Nakanishi K, Sakai M, Tanaka H, Tsuboi H, Hashimoto J, Hashimoto N, Tomiyama N (2013) Whole-body MR imaging in detecting phosphaturic mesenchymal tumor (PMT) in tumor-induced hypophosphatemic osteomalacia. Mag Reson Med Sci MRMS Off J Jpn Soc Mag Reson Med 12(1):47\u201352","journal-title":"Mag Reson Med Sci MRMS Off J Jpn Soc Mag Reson Med"},{"issue":"4","key":"1412_CR28","first-page":"4970","volume":"15","author":"Z Shi","year":"2018","unstructured":"Shi Z, Deng Y, Li X, Li Y, Cao D, Coossa VS (2018) CT and MR imaging features in phosphaturic mesenchymal tumor-mixed connective tissue: a case report. Oncol Lett 15(4):4970\u20134978","journal-title":"Oncol Lett"},{"issue":"2","key":"1412_CR29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00256-016-2548-7","volume":"46","author":"S Cowan","year":"2017","unstructured":"Cowan S, Lozano-Calderon SA, Uppot RN, Sajed D, Huang AJ (2017) Successful CT guided cryoablation of phosphaturic mesenchymal tumor in the soft tissues causing tumor-induced osteomalacia: a case report. Skeletal Radiol 46(2):273\u2013277","journal-title":"Skeletal Radiol"},{"issue":"1","key":"1412_CR30","first-page":"46","volume":"19","author":"Y Kaneuchi","year":"2016","unstructured":"Kaneuchi Y, Hakozaki M, Yamada H, Hasegawa O, Tajino T, Konno S (2016) Missed causative tumors in diagnosing tumor-induced osteomalacia with (18) F-FDG PET\/CT: a potential pitfall of standard-field imaging. Hell J Nucl Med 19(1):46\u201348","journal-title":"Hell J Nucl Med"},{"issue":"4","key":"1412_CR31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/eje.0.1450469","volume":"145","author":"AE Nelson","year":"2001","unstructured":"Nelson AE, Mason RS, Robinson BG, Hogan JJ, Martin EA, Ahlstr\u00f6m H et al (2001) Diagnosis of a patient with oncogenic osteomalacia using a phosphate uptake bioassay of serum and magnetic resonance imaging. Eur J Endocrinol 145(4):469\u2013476","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1412_CR32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s00259-008-0755-8","volume":"35","author":"C von Falck","year":"2008","unstructured":"von Falck C, Rodt T, Rosenthal H, L\u00e4nger F, Goesling T, Knapp WH, Galanski M (2008) (68)Ga-DOTANOC PET\/CT for the detection of a mesenchymal tumor causing oncogenic osteomalacia. Eur J Nucl Med Mol Imaging 35(5):1034","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1412_CR33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cen.12426","volume":"81","author":"S Jadhav","year":"2014","unstructured":"Jadhav S, Kasaliwal R, Lele V, Rangarajan V, Chandra P, Shah H et al (2014) Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET\/CT vs somatostatin receptor-based functional scans: a series of nine patients. Clin Endocrinol 81(1):31\u201337","journal-title":"Clin Endocrinol"},{"issue":"11","key":"1412_CR34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/RLU.0b013e31818866bf","volume":"33","author":"M Duet","year":"2008","unstructured":"Duet M, Kerkeni S, Sfar R, Bazille C, Liot\u00e9 F, Orcel P (2008) Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia. Clin Nucl Med 33(11):752\u2013756","journal-title":"Clin Nucl Med"},{"issue":"9308","key":"1412_CR35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","volume":"359","author":"SM Jan de Beur","year":"2002","unstructured":"Jan de Beur SM, Streeten EA, Civelek AC, McCarthy EF, Uribe L, Marx SJ et al (2002) Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet (London, England) 359(9308):761\u2013763","journal-title":"Lancet (London, England)"},{"issue":"8","key":"1412_CR36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00003072-200208000-00007","volume":"27","author":"CA Garcia","year":"2002","unstructured":"Garcia CA, Spencer RP (2002) Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report. Clin Nucl Med 27(8):582\u2013583","journal-title":"Clin Nucl Med"},{"issue":"4","key":"1412_CR37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.2001.01056.x","volume":"54","author":"Y Rhee","year":"2001","unstructured":"Rhee Y, Lee JD, Shin KH, Lee HC, Huh KB, Lim SK (2001) Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy. Clin Endocrinol 54(4):551\u2013554","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1412_CR38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s13139-011-0095-7","volume":"45","author":"HJ Seo","year":"2011","unstructured":"Seo HJ, Choi YJ, Kim HJ, Jeong YH, Cho A, Lee JH et al (2011) Using (18)F-FDG PET\/CT to detect an occult mesenchymal tumor causing oncogenic osteomalacia. Nucl Med Mol Imaging 45(3):233\u2013237","journal-title":"Nucl Med Mol Imaging"},{"issue":"6","key":"1412_CR39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","volume":"26","author":"P Andreopoulou","year":"2011","unstructured":"Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler Peck CM, Wodajo FM et al (2011) Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res Off J Am Soc Bone Miner Res 26(6):1295\u20131302","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"3","key":"1412_CR40","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s12020-016-1092-5","volume":"54","author":"MM Slot-Steenks","year":"2016","unstructured":"Slot-Steenks MM, Hamdy NA, van de Sande MA, Vriens D, Cleven AH, AppelmanDijkstra NM (2016) Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma. Endocrine 54(3):642\u2013647","journal-title":"Endocrine"},{"issue":"6","key":"1412_CR41","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"Chong WH et al (2013) Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res Off J Am Soc Bone Miner Res 28(6):1386\u20131398","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"1","key":"1412_CR42","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","volume":"40","author":"K Agrawal","year":"2015","unstructured":"Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, Bhansali A (2015) Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med 40(1):e6\u2013e10","journal-title":"Clin Nucl Med"},{"issue":"1","key":"1412_CR43","first-page":"35","volume":"12","author":"SF Hodgson","year":"2006","unstructured":"Hodgson SF, Clarke BL, Tebben PJ, Mullan BP, Cooney WP 3rd, Shives TC (2006) Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy. Endocrine Pract Off J Am College Endocrinol Am Assoc Clin Endocrinol 12(1):35\u201342","journal-title":"Endocrine Pract Off J Am College Endocrinol Am Assoc Clin Endocrinol"},{"issue":"6","key":"1412_CR44","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s13139-018-0546-5","volume":"52","author":"S Ha","year":"2018","unstructured":"Ha S, Park S, Kim H, Go H, Lee SH, Choi JY et al (2018) Successful localization using 68Ga-DOTATOC PET\/CT of a phosphaturic mesenchymal tumor causing osteomalacia in a patient with concurrent follicular lymphoma. Nucl Med Mol Imaging 52(6):462\u2013467","journal-title":"Nucl Med Mol Imaging"},{"issue":"2","key":"1412_CR45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2012-3642","volume":"98","author":"RJ Clifton-Bligh","year":"2013","unstructured":"Clifton-Bligh RJ, Hofman MS, Duncan E, Sim I, Darnell D, Clarkson A et al (2013) Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT. J Clin Endocrinol Metab 98(2):687\u2013694","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1412_CR46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/RLU.0000000000000854","volume":"40","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhu Z, Zhong D, Dang Y, Xing H, Du Y et al (2015) 68Ga DOTATATE PET\/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia. Clin Nucl Med 40(8):642\u2013646","journal-title":"Clin Nucl Med"},{"issue":"4","key":"1412_CR47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.mric.2019.07.004","volume":"27","author":"T Woo","year":"2019","unstructured":"Woo T et al (2019) Radiographic\/MR imaging correlation of spinal bony outlines. Magn Reson Imaging Clin N Am 27(4):625\u2013640","journal-title":"Magn Reson Imaging Clin N Am"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-021-01412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-021-01412-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-021-01412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T10:41:04Z","timestamp":1640256064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-021-01412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1007\/s11547-021-01412-1","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,28]]},"assertion":[{"value":"29 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review article that does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Ethical standards from both the institution and the 1964 Declaration of Helsinki were respected during this study, and informed consent was obtained from subjects involved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}